Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
Abstract Patients with early-stage, hormone receptor–positive breast cancer with favorable clinicopathologic features are often not recommended for extended endocrine therapy. However, even patients with T1N0 disease remain at significant risk of distant recurrence up to 15 years following 5 years o...
Guardado en:
Autores principales: | Brock Schroeder, Yi Zhang, Olle Stål, Tommy Fornander, Adam Brufsky, Dennis C. Sgroi, Catherine A. Schnabel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92e90599335f479b9f2cb277f9642bd4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Statins and risk of breast cancer recurrence
por: Sakellakis M, et al.
Publicado: (2016) -
Weakly supervised temporal model for prediction of breast cancer distant recurrence
por: Josh Sanyal, et al.
Publicado: (2021) -
Decreased risk of breast cancer associated with oral bisphosphonate therapy
por: Mathew A, et al.
Publicado: (2012) -
Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
por: Zheng Han, et al.
Publicado: (2017) -
Author Correction: Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
por: Zheng Han, et al.
Publicado: (2018)